Introduction {#Sec1}
============

In recent years, with the change of lifestyle, the prevalence of CHD has increased rapidly, which has become a serious public health problem. Cardiac rehabilitation, as an important intervention measure, is of great significance to improving the clinical outcomes of CHD patients \[[@CR1]\]. However, patients' participation in hospital-based cardiac rehabilitation is subject to many factors such as traffic and work \[[@CR2]\]. Additionally, in a developing country like China, cardiac rehabilitation is not well developed and applied, because of unbalanced development of economy and technology among regions \[[@CR3]\]. Therefore, it is an important task to improve the rehabilitation participation rate of patients in clinical practice.

Scientific and technological development enables the application and popularization of electronic products such as smartphones. In order to make full use of achievements of scientific and technological development and improve the efficiency of rehabilitation, some clinical workers have proposed and carried out home-based telemonitored cardiac rehabilitation with support of internet technology \[[@CR4]--[@CR6]\]. With the advantages of flexibility in location and time, this scheme may help solve the shortcomings of conventional cardiac rehabilitation \[[@CR7]\]. Many studies abroad have proved the feasibility and effect of telemonitored cardiac rehabilitation \[[@CR8]--[@CR10]\]. But in China, telemonitored cardiac rehabilitation program was not yet mature; there were few studies on the acceptance and compliance to telemonitored rehabilitation of patients with CHD, or on the effect of telemonitored rehabilitation to these people. This study aimed to evaluate the application and effect of smartphone-based telemonitored exercise rehabilitation among CHD patients in China.

Methods {#Sec2}
=======

Study Design and Subject {#Sec3}
------------------------

This study was a single-center, prospective, randomized, controlled clinical trial. Patients who were enrolled in this study signed informed consent; then, they were randomly divided into telemonitored group (group A) and control group (group B) at the ratio of 1:1. All patients received cardiopulmonary exercise testing (CPET). After that, all of them were given exercise prescription according to their results of CPET. Exercise prescription was set according to their anaerobic threshold (AT). Exercise intensity was determined based on heart rates (HR). The target HR during exercise was set as heart rate\@AT (HR\@AT) ± 5 bpm. The exercise type was walking. Exercise frequency was 3--5 times per week, with each exercise duration of 30 min and 5--10 min of warm-up and relaxation before and after exercise \[[@CR11]\]. Both groups received routine discharge education and outpatient follow-up which included advice to exercise regularly. This study passed the review by the Ethics Committee of Peking University Third Hospital (approval number 2014203), and followed the CONSORT reporting standard.

Inclusion Criteria

Inclusion criteria were the following: (1) age≤ 75 years old; (2) diagnosed as stable CHD by coronary angiography; (3) without physical or mental disorders affecting exercise; (4) skillful in using software such as WeChat and telemonitoring software.

Exclusion Criteria

Exclusion criteria were as follows: (1) with congestive heart failure of class III--IV under New York Heart Association (NYHA) Classification or class III--IV under Killip Classification; (2) accompanied by severe diseases of other systems, such as HIV, malignant tumors, severe primary liver, and kidney diseases; (3) coexisting with clinical conditions with life expectancy of less than 6 months, or unable to complete the follow-up; (4) refused to sign the informed consent or unable to exercise or not willing to cooperate; (5) participated in other interventional clinical studies at the time of enrollment or within 30 days before enrollment.

Intervention {#Sec4}
------------

Researchers helped install telemonitoring software (MEMRS-CRS, developed by Medicus) on patients' smartphones in group A, distributed heart rate belts (Suunto, provided by Medicus) for monitoring patients' HR, and instructed patients in wearing heart rate belts and using the software. Medical staff monitored patients' exercise frequency, blood pressure (BP) and HR before and after exercise, investigated fatigue degree after exercise using the Borg Rating of Perceived Exertion Scale (RPE 6-20) \[[@CR12]\] at the Medicus monitoring device computer terminal, and communicated with patients weekly through text messaging (WeChat or other applications) and telephone call. Feedback was provided on patients' exercise status (including the frequency, intensity and time of exercise, and blood pressure and HR response before and after exercise), questions about device usage, and exercise prescriptions. The frequency of feedback was usually once a week. Researchers checked the information on the website every day commonly. If patients have questions, they would answer them in time. The feedback was based on cognition and behavior theory and was personalized. For both of the two arms, the participants did not accept any in-hospital cardiac rehabilitation.

Baseline Information {#Sec5}
--------------------

Patients' demographic information was collected, including gender, age, height, weight, occupation, and education; exercise habits; application of smartphones; past medical history; diagnosis and treatment of CHD; and blood test, echocardiography, and CPET results.

Follow-up {#Sec6}
---------

Patients' CPET and echocardiography parameters, exercise habits, blood test information, including blood cell count, liver function, kidney function, blood lipid, and blood glucose, and the incidence of clinical events and adverse events were collected after 6 months of intervention.

Endpoints {#Sec7}
---------

The primary endpoint was the difference between the two groups in changes of exercise tolerance, represented by VO~2peak~ and other CPET parameters during follow-up. Secondary endpoints included the difference of exercise habits (According to the American College of Sports Medicine (ACSM) 10th edition of "'ACSM' Guidelines for Exercise Testing and Prescription," exercise 3--5 times a week, each exercise time (\> 30 min) means having exercise habits, and the rest for no exercise \[[@CR11]\]), blood test and echocardiographic parameters, control rate of blood lipid and blood glucose, and incidence of adverse events after 6 months of follow-up.

Statistical Methods {#Sec8}
-------------------

### Sample Size {#Sec9}

According to relevant literature, VO~2peak~ increased by 14.3% in the telemonitored rehabilitation group and 0% in the conventional rehabilitation group \[[@CR13]\]. Using bilateral test with an *α* of 0.05 and *β* of 0.2 (efficacy of 80%) and a case distribution ratio of 1:1 in the two groups, it was estimated that 48 patients were needed in each group. Considering 10% dropouts and other factors, this study needed to enroll a total of 106 patients, including 53 in the experimental group and 53 in the control group.

### Data Analysis {#Sec10}

SPSS software version 20.0 (IBM, Chicago, IL, USA) was used for data analysis. Quantitative variables were expressed as mean ± standard deviation (*x* ± S) in normal distributions, and as median and interquartile range in cases that were not normally distributed. Qualitative variables were expressed as percentages. Chi-square test, independent sample *t* test, and repeated measures ANOVA were used to compare variables between the two groups. Chi-square test and logistics regression were used for correlation analysis. The level of significance was defined as *P* = 0.05.

Results {#Sec11}
=======

Baseline Data {#Sec12}
-------------

One hundred thirty-three CHD patients who visited the Department of Cardiology, Peking University Third Hospital, from September 2017 to September 2018 were screened for the purpose of this study, of which 13.5% refused to participate and 6.8% fulfilled exclusion criteria, and 106 patients were selected eventually. Of those 106 CHD patients, a total of 96 (48 in group A and 48 in group B) completed the follow-up. None of the patients had atrial fibrillation. In group A, the average age of patients was 54.17 ± 8.76 years old, and 43 patients (89.60%) were male. For the five dropouts in group A, one failed to master the application of mobile phone monitoring software; one withdrew due to work reasons; three failed to continuously wear monitoring device. In group B, the average age of patients was 54.83 ± 9.13 years old, and 40 patients (83.33%) were male. For the five dropouts in group B, two withdrew due to work or family reasons; three refused to visit the hospital for follow-up after 6 months. Figure [1](#Fig1){ref-type="fig"} presents the flow chart of the study.Fig. 1Flow chart of the study

There was no significant difference in baseline data between the two groups (*P* \> 0.05), as shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}.Table 1Comparison between the two groups in medical historyItemsGroup A number (%)/mean ± SGroup B number (%)/mean ± S*χ*^2^/*tP* valueMale43(89.60)40(83.33)0.8010.371Age54.17 ± 8.7654.83 ± 9.13− 0.3650.716Height (cm)170.50 ± 6.60170.10 ± 6.360.2990.765Weight (kg)77.84 ± 12.4575.93 ± 13.510.8540.473High school or above27(56.2)19(39.6)2.6710.102Smoking32(66.7)26(54.2)1.5680.210Myocardial infarction26(54.2)22(45.8)0.6670.414Hypertension29(60.4)37(77.1)3.1030.078Hyperlipidemia37(77.1)31(64.6)1.8150.178Diabetes mellitus26(54.2)20(41.7)1.5030.220Cerebral infarction2(4.2)0(0)2.4030.475Family history22(45.8)18(37.5)0.6860.408Exercise habits36(75.0)34(70.8)0.2110.646Numbers of lesion vessel2.06 ± 0.901.85 ± 0.921.1240.264Complete revascularization23(47.9)32(66.7)3.4480.063Statin44(91.7)46(95.8)0.1780.673Βeta-blocker28(58.3)28(58.3)0.0001.000Aspirin35(72.9)34(70.8)0.0520.820Clopidogrel22(45.8)28(58.3)1.5030.220ACEI/ARB15(31.2)17(35.4)0.1880.665Table 2Comparison of examination results between the two groups at baselineItemsGroup A, mean ± SGroup B, mean ± S*t* test*P* valueSBP\@baseline (mmHg)125.47 ± 16.19128.26 ± 13.89− 0.8130.419DBP\@baseline (mmHg)76.56 ± 12.3577.74 ± 10.81− 0.4500.654HGB(g/L)148.14 ± 11.82142.28 ± 17.111.7680.081Blood glucose (mmol/L)6.45 ± 1.586.91 ± 1.82− 1.2760.205TC(mmol/L)3.42 ± 0.933.54 ± 0.94− 0.6310.530TG (mmol/L)1.68 ± 1.071.85 ± 1.02− 0.762− 0.448LDL-C (mmol/L)1.96 ± 0.692.07 ± 0.83− 0.6780.500HDL-C (mmol/L)1.04 ± 0.270.98 ± 0.201.0510.296ALT (U/L)28.58 ± 12.7825.35 ± 16.101.0590.293AST (U/L)25.16 ± 20.2221.57 ± 11.691.0400.301Scr (μmol/L)88.12 ± 15.4787.66 ± 15.410.1310.896UA (μmol/L)334.63 ± 123.42323.64 ± 138.700.3750.709LAD (mm)34.70 ± 6.2135.14 ± 5.74− 0.3440.731LAA (cm^2^)18.92 ± 3.0719.11 ± 3.11− 0.2850.777LVEDd (mm)49.99 ± 5.4349.43 ± 4.920.5030.616LVEDs (mm)32.22 ± 7.0031.03 ± 6.320.8320.408LAP (mmHg)9.61 ± 2.6510.32 ± 3.50− 1.0720.287EF (%)63.98 ± 10.7066.25 ± 9.06− 1.0750.285VO~2peak~ (mL/kg/min)20.40 ± 4.5718.83 ± 3.981.7710.080VO~2peak~ pred%67.45 ± 13.4864.02 ± 13.361.2300.222HR~peak~ (bpm)130.77 ± 16.52123.93 ± 17.51.9460.055VO~2~/HR\@VO~2peak~12.09 ± 2.7611.62 ± 2.860.7980.427SBP\@VO~2peak~ (mmHg)170.29 ± 32.36174.20 ± 30.96− 0.5910.556DBP\@VO~2peak~ (mmHg)77.42 ± 10.3476.16 ± 13.500.5040.615AT (mL/kg/min)12.35 ± 2.7511.60 ± 2.471.3980.165HR\@AT (bpm)103.15 ± 12.78100.75 ± 11.670.9330.353VO~2~/HR\@AT9.29 ± 2.018.74 ± 2.271.1990.549VE/VCO~2~\@AT28.50 ± 3.6329.89 ± 3.71− 1.8100.074VE/VCO~2~ slope28.41 ± 4.9829.87 ± 4.39− 1.4940.139OUES1679.85 ± 419.081578.35 ± 368.371.2340.221Quantitative variables are expressed as mean ± standard deviation in normal distributions. *SBP*, systolic blood pressure; *DBG*, diastolic blood pressure; *HGB*, hemoglobin; *TC*, total cholesterol; *TG*, triglyceride; *LDL-C*, low-density lipoprotein cholesterol; *HDL-C*, high-density lipoprotein cholesterol; *Scr*, serum creatinine; *UA*, uric acid; *LAD*, left atrial diameter; *LAA*, left atrial area. *LVEDd*, end-diastolic diameter of left ventricle; *LVEDs*, end-systolic diameter of left ventricle; *LAP*, left atrial pressure; *EF*, ejection fraction; *VO*~*2peak*~, peak oxygen uptake: *VO*~*2peak*~ *pred%*, percentage of predicted peak oxygen uptake; *HR*~*peak*~, peak heart rate; *VO*~*2*~*/HR*, oxygen pulse; *AT*, anaerobic threshold; *HR\@AT*, heart rate at anaerobic threshold; *VE/VCO*~*2*~, ventilatory equivalent for carbon dioxide; *VE/VCO*~*2*~ *slope*, the relationship between change in V̇E and V̇CO~2~ during incremental exercise; *OUES*, oxygen uptake efficiency slope

Qualitative variables are expressed as number (percentage). Quantitative variables are expressed as mean ± standard deviation in normal distributions. *ACEI*, angiotensin-converting enzyme inhibitor; *ARB*, angiotensin receptor blocker

Rehabilitation Effectiveness {#Sec13}
----------------------------

The exercise frequency of patients in group A was 5.1 ± 0.6 times a week; each time was 31.4 ± 4.5 min. The duration of HR reaching the target HR during exercise accounted for (94.2 ± 6.4)% of the total exercise time. In addition, 91.7% (44/48) of the participants in the intervention group were satisfied with the content and frequency of feedback; others were not completely satisfied with the feedback because they were not proficient in uploading information even with guidance of researchers.

### Improvement in exercise tolerance {#Sec14}

CPET parameters, mainly VO~2peak~, were used to measure patients' exercise tolerance in this study. The VO~2peak~ values of the two groups of patients before and after intervention were analyzed by two-factor and two-level repeated measures ANOVA. Results showed that the main effect of intervention was statistically significant (*P* = 0.007), indicating that there was significant difference in VO~2peak~ between the two groups regardless of the time factor. The main effect of time was also statistically significant (*P* = 0.033), indicating that VO~2peak~ values of patients changed over time regardless of the intervention factor. The interaction between time effect and intervention effect was not statistically significant (*P* = 0.056) (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Interaction profile of VO~2peak~

The VO~2peak~ after intervention in group A and group B was 22.29 ± 4.79 (mL/kg/min) and 19.07 ± 5.33 (mL/kg/min), respectively (*t* = 3.012, *P* = 0.003), indicating that there were statistically significant differences in VO~2peak~ between the two groups after intervention.

During the follow-up period, other indicators that could reflect patients' exercise tolerance and cardiopulmonary function with statistical differences included VO~2peak~ pred%, HR~peak~, AT, VE/VCO~2~\@AT, VE/VCO~2~ slope, and OUES (Table [3](#Tab3){ref-type="table"}).Table 3Indicators with statistically significant differences between the two groups after 6 monthsIndicatorGroup AGroup B*t* test*P* valueVO~2peak~ pred%72.05 ± 14.9864.66 ± 17.042.1600.034HR~peak~ (bpm)135.60 ± 16.38121.61 ± 15.224.171\< 0.001AT (mL/kg/min)13.42 ± 3.9511.64 ± 3.462.2530.027VE/VCO~2~\@AT27.24 ± 2.8729.52 ± 3.71− 3.1610.002VE/VCO~2~ slope27.78 ± 3.9129.52 ± 3.71− 1.8640.002OUES1777.38 ± 416.501565.99 ± 381.522.4950.014Quantitative variables are expressed as mean ± standard deviation in normal distributions; *VO*~*2peak*~ *pred%*, percentage of predicted peak oxygen uptake; *HR*~*peak*~, peak heart rate; *AT*, anaerobic threshold; *VE/VCO*~*2*~*\@AT*, ventilatory equivalent for carbon dioxide at anaerobic threshold; *VE/VCO*~*2*~ *slope*, the relationship between change in V̇E and V̇CO~2~ during incremental exercise; *OUES*, oxygen uptake efficiency slope

### Improvement in Exercise Habits {#Sec15}

Changes of patients' exercise habits from baseline to 6 months are presented in Table [4](#Tab4){ref-type="table"}. In each group, 9 patients (18.8%) did not have exercise habit when enrolled, but insisted on exercise after 6 months. Six patients (12.5%) in group B had exercise habits when enrolled, but failed to keep exercise after 6 months. Other patients had no change in exercise habits. There was a statistically significant difference in changes of exercise habits between the two groups (*P* = 0.020).Table 4Changes of patients' exercise habits before and after intervention in the two groupsGroupWhether patients have exercise habits before and after intervention*χ*^2^*P* valueNo/no, number (%)No/yes, number (%)Yes/no, number (%)Yes/yes, number (%)9.8260.020A3 (6.2)9 (18.8)0 (0.0)36 (75.0)B5 (10.4)9 (18.8)6 (12.5)28 (58.3)

Results of univariate and multivariate analyses of patients' exercise habits during the follow-up period are shown in Table [5](#Tab5){ref-type="table"}. Whether one had exercise habit during the follow-up period only had statistical correlation with study group and baseline exercise habits, but no statistical correlation with other factors.Table 5Multivariate analysis of patients' exercise habits after interventionVariables includedBS.E.Wals*P*OR95% confidence intervalUnder telemonitored monitoring1.5310.7124.6220.0324.6241.145\~18.677With exercise habits at baseline1.5910.6276.4290.0114.9071.435\~16.784

### Others {#Sec16}

During the follow-up period, there were no statistically significant differences in biochemical and echocardiographic parameters between the two groups. There was no significant change in the control rate of blood lipid and blood glucose after 6 months of follow-up. No serious complications or adverse events occurred during follow-up.

Discussion {#Sec17}
==========

Currently, cardiac rehabilitation for patients with CHD in China, especially rehabilitation in the out-of-hospital setting, is still not perfect. Limitations in various aspects lead to poor participation of patients in rehabilitation, especially for the elderly. In view of this, we designed this research program and made full use of widely used smartphones and telemonitoring devices to extend the cardiac rehabilitation setting from hospitals to homes \[[@CR14]\]. Combining HR monitoring during exercise with personalized feedback from patients, this study contributes to the domestic research system of smartphone-based, long-term intervention for patients with stable CHD. Therefore, it is a practical and valuable study for patients with stable CHD.

Improvement in Exercise Tolerance {#Sec18}
---------------------------------

Results of this study showed that patients in the intervention group had more significant improvement in exercise tolerance (represented by VO~2peak~), compared with those in the control group. In this study, we used CPET to evaluate patients' exercise tolerance. For CPET, pulmonary gas exchange is measured by recording and analyzing exhaled gas of patients so as to further assess exercise-related physiology characteristics of cardiovascular, respiratory, musculoskeletal, and cellular oxidative systems \[[@CR15], [@CR16]\]. It provides patients with comprehensive and accurate information about their exercise tolerance and exercise limitation. VO~2peak~ is the VO~2~ value the tester attained with maximum effort in the incremental load exercise test and is significantly correlated with individual exercise tolerance and disease prognosis \[[@CR15]--[@CR18]\]. By analyzing changes of VO~2peak~ in the two groups before and after intervention, this study found statistically significant difference in VO~2peak~ between the two groups after 6 months of intervention and changes of VO~2peak~ with time in both groups. It must be noted that both study arms indicated a tendency towards improvement regardless of intervention; however, the improvement was more obvious in group A. Frederix's study \[[@CR19]\] and Duscha's study \[[@CR20]\] both found that VO~2peak~ improved in the intervention group after telemonitored rehabilitation, while this variable did not improved in the conventional rehabilitation group. However, Kraal et al. \[[@CR8]\] showed that both the telemonitored monitoring group and the conventional rehabilitation group had improvement in exercise tolerance after regular rehabilitation. All of those studies demonstrated the effects of telemonitored rehabilitation were similar to or even better than those of conventional rehabilitation. In this study, HR changes of patients in intervention group during exercise were monitored in real time by smartphones and electronic monitoring devices, and medical staff regularly gave feedback to patients on their exercise and physical parameters with the aid of computer monitoring terminal, thereby improved patients' understanding of their own physical condition and also external support received during rehabilitation process. It may be an important reason for patients' improvement in rehabilitation compliance with exercise intensity, time, and frequency, and then promoted the improvement of patients' exercise tolerance.

Additionally, it was found that VO~2peak~ pred%, HR~peak~, AT, VO~2~/HR\@AT, VE/VCO~2~\@AT, VE/VCO~2~ slope, and OUES were significantly better in the intervention group than in the control group after 6 months of intervention (*P* \< 0.05). In a study of 142 patients with CHD, Popovic et al. found significant improvement of patients in VO~2peak~, VO~2~/HR\@VO~2peak~, VE/VCO~2~ slope, and OUES after 3 to 6 months of cardiac rehabilitation \[[@CR21]\]. Although changes of specific indicators are not exactly the same in those two studies, both of them demonstrated certain effects of monitored cardiac rehabilitation. Previous studies have confirmed the practical significance of improvement in the above indicators \[[@CR22], [@CR23]\]. As AT, VO~2~/HR\@AT, VE/VCO~2~, and OUES are all indicators for submaximal exercise, this study is of great practical significance for patients who can only perform submaximal exercise tests.

Improvement in Exercise Habits {#Sec19}
------------------------------

Results showed that there were statistically significant differences in exercise habits between the two groups during the follow-up period (*P* = 0.020). During follow-up, the proportion of patients with exercise habits in telemonitored group was 93.8%, significantly higher than that in the conventional follow-up group (77.1%) (*P* = 0.021). But this proportion was still lower compared with the study results by Piotrowicz, which showed that up to 99.2% of patients were completely and partially compliant with telemonitored rehabilitation \[[@CR24]\]. However, the period of study by Piotrowicz (4 weeks) was different from that of this study. Therefore, it could not fully indicate that the rehabilitation compliance of patients in the former study was better than our research. In this study, whether one had exercise habit or not during the follow-up period only had statistical correlation with intervention and baseline exercise habits (*P* \< 0.05). It indicated that telemonitoring could improve patients' compliance with exercise rehabilitation and those who have had exercise habits before the intervention were more likely to maintain exercise habits. Similar results have been obtained in foreign studies. In a study of 53 patients with chronic stable heart failure, Hwang \[[@CR2]\] showed that the compliance rates of telemonitored rehabilitation group and conventional rehabilitation group were 71% and 30%, respectively. In a study of rehabilitation among patients with myocardial infarction, Varnfield et al. \[[@CR25]\] showed that the participation rate of patients in the telemonitored rehabilitation group was up to 94%. Timely feedback from medical staff may promote the maintenance and development of patients' exercise habits.

Innovation in Telemonitored Cardiac Rehabilitation {#Sec20}
--------------------------------------------------

During the implementation of this study, patients in group A wore heart rate belts while exercising. Through observing HR changes in real time by mobile phones, they could control the exercise intensity. Technological advance has made it possible for patients under telemonitoring to obtain reliable data support during exercise \[[@CR26]\]. In addition, CPET, a gold standard with convenient and safe operation, was adopted for assessing patients' exercise tolerance and developing exercise prescriptions \[[@CR11]\]. With an intervention period of 6 months, which was much longer than the intervention period of other telemonitored intervention studies nationwide \[[@CR27], [@CR28]\], this study can provide reference for telemonitored cardiac rehabilitation practice in China.

Limitations and Prospects {#Sec21}
-------------------------

This study was limited by smartphones using and communicational methods. What's more, patients using the mobile devices may be more comfortable with using mobile devices and also more engage in their own healthcare. Therefore, we need to further explore a more widely applicable telemonitored intervention mode. In addition, it must be noted that researchers' feedback to patients would also have a certain impact on patients' exercise habits. Because of absenting of subsequent follow-up after half-year's intervention, long-term effects of telemonitored rehabilitation cannot be determined. Further large-scale, multi-center studies involving different diseases and hospitals of different levels and in different regions are still needed to further clarify the value of telemonitored cardiac rehabilitation. In this study, we did not conduct an explicit investigation on the economic cost of the participants, so we had no clear knowledge about the cost-effectiveness of the telemonitored rehabilitation program. Additionally, if telemonitored rehabilitation is widely used in clinic in the future, considering the safety of remote monitoring equipment, protecting patients' privacy is indeed an important part of clinical work.

CHD

:   Coronary heart disease

CPET

:   Cardiopulmonary exercise testing

HR

:   Heart rate

BP

:   Blood pressure

VO~2peak~

:   Peak oxygen uptake

VO~2peak~ pred%

:   Percentage of predicted peak oxygen uptake
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:   Peak heart rate
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:   Anaerobic threshold
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:   Heart rate at anaerobic threshold
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:   Rating of perceived exertion

VO~2~/HR

:   Oxygen pulse

VE/VCO~2~

:   Ventilatory equivalent for carbon dioxide

VE/VCO~2~ slope

:   The relationship between change in V̇E and V̇CO~2~ during incremental exercise
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:   Oxygen uptake efficiency slope
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